Changeflow GovPing Healthcare FDA Consultation on i-Health Inc. Culturelle Gu...
Priority review Consultation Added Consultation

FDA Consultation on i-Health Inc. Culturelle Gummies

Favicon for www.regulations.gov Regs.gov: Food and Drug Administration
Detected
Email

Summary

The FDA has opened a comment period regarding i-Health Inc.'s Culturelle Women's Probiotic + Multivitamin Gummies. This consultation seeks public input on the product, with specific details available via the provided link.

View original document View source feed page

What changed

The FDA is soliciting public comments on i-Health Inc.'s Culturelle Women's Probiotic + Multivitamin Gummies, identified under docket number FDA-2025-S-0024. While no specific documents are available for download, the consultation indicates a review or potential regulatory action concerning this dietary supplement.

Regulated entities, particularly manufacturers of dietary supplements and related products, should review the details of this consultation and consider submitting comments by the deadline. Failure to engage with such consultations can lead to unforeseen regulatory changes impacting product formulations, labeling, or marketing. The specific comment deadline is not provided in this notice, but prompt review is advised.

What to do next

  1. Review the FDA consultation notice for i-Health Inc. Culturelle Gummies.
  2. Consider submitting comments to the FDA regarding the product.
  3. Monitor further FDA actions or guidance related to this product.

Archived snapshot

Mar 18, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

There are no documents available to view or download

Attachments 1

i-Health Inc. - Culturelle Women's Probiotic + Multivitamin Gummies

More Information
- Author(s) HFP
Download

Related changes

Favicon for www.regulations.gov Vessey 1986 Scientific Reference as FDA Background Material
Routine Apr 16, 2026 • Regs.gov: Food and Drug Administration • Healthcare
Favicon for www.regulations.gov Bernier 2009 FDA Regulatory Proceeding Citation
Routine Apr 16, 2026 • Regs.gov: Food and Drug Administration • Healthcare
Favicon for www.regulations.gov FDA Package Insert NDA 021323 Background Material
Routine Apr 16, 2026 • Regs.gov: Food and Drug Administration • Healthcare

Get daily alerts for Regs.gov: Food and Drug Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

Source

Favicon for www.regulations.gov
Regs.gov: Food and Drug Administration regulations.gov/search?agencyIds=FDA&sortBy=postedDate&sortDirection=desc
Healthcare

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Press inquiries →

Classification

Agency
FDA
Instrument
Consultation
Legal weight
Non-binding
Stage
Consultation
Change scope
Substantive

Who this affects

Applies to
Food manufacturers Manufacturers
Geographic scope
National (US) National (US)

Taxonomy

Primary area
Food Safety
Operational domain
Compliance
Topics
Dietary Supplements Probiotics

Browse Categories

Agriculture & Food Safety 65 AI Regulation 3 Banking & Finance 319 Consumer Protection 48 Courts & Legal 361 Data Privacy & Cybersecurity 77 Defense & National Security 51 Education 24 Energy 100 Environment 86 Environmental & Energy 17 Environmental Regulation 7 Financial Regulation 2 Government & Legislation 278 Government Operations 97 Healthcare 135 Healthcare & Life Sciences 11 Housing 16 Immigration 8 Immigration & Border Control 2 Insurance 58 Labor & Employment 115 Legal & Judicial 16 Pharma & Drug Safety 101 Pharma & Healthcare 1 Public Health 2 Real Estate & Housing 32 Sanctions & Export Controls 1 Securities & Investments 15 Securities & Markets 103 Securities Regulation 6 Tax 65 Tax & Revenue 8 Telecom & Technology 47 Trade & Commerce 3 Trade & Sanctions 135 Transportation 63

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!